MS is a chronic disease that affects an estimated 2.3 million people around the world, including an estimated 400,000 people in the United States, and while there are many approved drugs aimed at keeping RMS in check, approximately 10 percent to 15 percent of people with MS are diagnosed with PPMS, for which there are no approved treatments.